(Q42977154)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

Maria Ines de Moura Campos Pardini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

Jeane Eliete Laguila Visentainer

21 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Giovanni Faria Silva

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

A V Marangon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R A Moliterno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A M Sell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C F V de Moraes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R M T Grotto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

D S De Pauli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

30 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunogenetics

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

296-302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22284614%20AND%20SRC:MED&resulttype=core&format=json

Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to alpha-interferon treatment in patients with chronic hepatitis C.

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Genotype distributions of hepatitis C virus in São Paulo, Brazil: rare subtype found

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Geographic distribution of hepatitis C virus genotypes in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Hepatitis C and treatment with pegylated interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Noncytolytic control of viral infections by the innate and adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Performing the exact test of Hardy-Weinberg proportion for multiple alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Hla-Cw7 allele as predictor of favorable therapeutic response to interferon-alpha in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Possible association between HLA antigens and the response to interferon in Japanese patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Clinical significance of hepatitis C virus genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Hepatitis C virus infection in Eastern Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Color and genomic ancestry in Brazilians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Interferons and their actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Racial differences in HLA class II associations with hepatitis C virus outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Host genetic determinants in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Polymorphism in the Human Major Histocompatibility Complex and Early Viral Decline during Treatment of Chronic Hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X

Human leukocyte antigen class I and II alleles and response to interferon-alpha treatment, in Taiwanese patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2012.01088.X